Catalyst Pharmaceutical
CPRX
CPRX
88 hedge funds and large institutions have $314M invested in Catalyst Pharmaceutical in 2019 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 25 increasing their positions, 27 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
7% less repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 27
43% less call options, than puts
Call options by funds: $683K | Put options by funds: $1.19M
Holders
88
Holding in Top 10
3
Calls
$683K
Puts
$1.19M
Top Buyers
| 1 | +$43.2M | |
| 2 | +$9.31M | |
| 3 | +$5.55M | |
| 4 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$5.1M |
| 5 |
HRCM
Hawk Ridge Capital Management
Los Angeles,
California
|
+$3.34M |
Top Sellers
| 1 | -$4.78M | |
| 2 | -$2.1M | |
| 3 | -$1.6M | |
| 4 |
DMK
David M. Knott
|
-$523K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
-$394K |